SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Greg22 who wrote (18679)2/12/1999 12:27:00 AM
From: Andreas Samson  Read Replies (1) of 23519
 
No one needs to manipulate Vivus, the bottom line speaks for itself. Drop a graph of MUSE domestic script numbers for the last five quarters, over a graph of the stock price in the same time period, and you will see that they overlap nearly exactly.

Among those who are long, there appears to be a constitutional inability to come to grips with the fact that 75% of the people who used MUSE in 1997 walked away from the product upon the arrival of Viagra. Marketing, for this consumer base, was not the issue. They were already using the drug. And they just walked away.

You can study Level II charts until your eyes glaze over, you can hang on every little tick in volume, every little marketing partnership rumor on SI or Yahoo!, none of it will change this Iron Truth: people don't want to use MUSE if they can avoid it, and, Viagra works much better than VVUS shareholders would care to admit.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News